New Funding Opportunities: Diversity, Inclusion and Breast Cancer Disparities
Conquer Cancer, the ASCO Foundation and Breast Cancer Research Foundation (BCRF) are proud to announce the following new grants focusing on Diversity, Inclusion and Breast Cancer Disparities. We ask for your help in spreading the word about these funding opportunities.
BCRF is a nonprofit organization committed to achieving prevention and a cure for breast cancer. BCRF is committed to diversity, equity and inclusion, and has signed the Tigerlily Diversity and Inclusion Pledge for Women of Color. More specifically, BCRF is actively working to: improve diversity within its organization at all levels, from staff and leadership to scientists funded; educate people of color diagnosed with breast cancer about the benefits of participating in clinical trials; continue to maintain—and expand—a robust research portfolio that attacks racial disparities in breast cancer outcomes and care from all angles.
Conquer Cancer is the philanthropic affiliate of the American Society of Clinical Oncology (ASCO). On August 12, ASCO published a policy statement calling for new actions to reduce disparities in cancer outcomes affecting racial and ethnic minorities, rural populations, sexual and gender minorities, people without insurance, and other disadvantaged populations. The policy statement makes a series of recommendations to ensure equitable access to care and research, to guide both ASCO’s own programs and the work of the broader oncology community.
Advanced Clinical Research Award (ACRA) for Diversity and Inclusion
This is a three-year $450,000 grant that is designed with the primary goal of increasing diversity in the oncology workforce and cancer research. Awards will be given to mid-career investigators who identify as members of racial and/or ethnic groups historically underrepresented in academic medicine and wish to conduct original breast cancer research not currently funded. Click here for more details. LOI Deadline on Oct 15, 2020.
Career Development Award (CDA) and Young Investigator Awards (YIA) for Diversity, Inclusion and Breast Cancer Disparities
These grants are designed to address 1) the underrepresentation of minorities and people of color in the oncology workforce and 2) issues of health equity and disparate breast cancer outcomes in underserved and minority communities. Applicants must identify as a member of a racial and/or ethnic group historically underrepresented in academic medicine planning a career in breast cancer research, OR, be of any racial and/or ethnic background planning an investigative career in clinical oncology with a research focus on breast cancer disparities.
The CDA is a three-year $200,000 grant for clinical investigators who are in their first few years of faculty appointment and seeking to establish an independent clinical cancer research program. Click here for the RFP. Application Deadline on Oct 29, 2020.
The YIA is a one-year $50,000 grant for promising investigators as they transition from a fellowship program to faculty appointment and seeking to build a career in clinical cancer research. Click here for the RFP. Application Deadline on Oct 29, 2020.
For questions on these exciting funding opportunities, please reach out to email@example.com.